Conference Agenda

8th Annual BFC HealthCare Conference

Sunday, January 12, 2025 -- The St. Regis San Francisco

  • TIME
    Sunday, January 12, 2025
  • 08:00 – 09:00
    Registration
  • 09:00 – 09:15
    Opening Remark – State of Healthcare Investment
    Speaker:
    David Chen, Managing Director, BFC Group
  • 09:15 – 10:15
    Faith to Incubate: Global Biotech Investment Trends and Focus
    Moderator:
    Seamus Jiang, U.S./China Cross-border Deals Leader, Managing Director, PwC
    Panelist:
    Tony Liu, Chairman and CEO, AbelZeta Pharma
    Frank Nestle, Partner and CEO of 3DC, Deerfield
    Ricky Sun, Partner, Bain Capital
    JeffZhou, Executive Director, J.P. Morgan
    Fang Ming, Managing Director, Redmile Group
  • 10:15 – 11:15
    Big Pharma, Big Synergy: Harnessing the Power of Strategic Collaborations
    Moderator:
    Thijs Spoor,Chief Executive Officer,Perspective Therapeutics
    Panelist:
    Rene Fuertig, Global Head CNS BD&L, Boehringer Ingelheim
    Marcel Reichen, Head of Search & Evaluation Radioligand Therapies at Corporate & Business Development, Novartis
    Matthieu Merlin, Head of Business Development General Medicines GBU, Sanofi
    Johan Verbeeck, Vice President Business Development, Oncology, Johnson & Johnson Innovative Medicine
    Dominic McDonald, Executive Director, Search & Evaluation & Oncology, GSK
  • 11:15 – 11:45
    Coffee Break
  • 11:45 – 12:45
    Navigating the Complexities of Cross-Border Licensing in a Globalized Market
    Moderator:
    Lila Hope, Partner, Cooley
    Panelist:
    Marya Postner, Partner, Cooley
    Maha Radhakrishnan, Executive Partner, Sofinnova Investmentss
    Ying Wang Schmidt, Senior Director, Business Development Project Leader, Roche
    Kevin Penghui Chen, Founding Partner, BioTrack Capita
  • 12:45 – 14:00
    Lunch Reception
  • 14:00 – 17:00
    Company Road Show
  • 17:00 – 18:00
    Emerging Licensing Trends: The Impact of Game-Changing NewCos
    Moderator:
    Patrick Loofbourrow, Partner, Cooley
    Panelist:
    Andrew Lam, Managing Director, Head of Biotech Private Equity, Allybridge
    Cory Freedland, Partner, Samsara Biocapital
    Shaan Gandhi, Vice President and Head of Strategic Partnerships, Pfizer Ignite
    Birgit Reitmaier, Executive Director, Head of BD Asia Pacific, Merck KGaA, Darmstadt, Germany
    Jeff Zechnich, PwC, Partner
More panelists to be announced
Register